There are so many people out there who are weary to start a journey with GLP-1s for the sole reason of thinking they cant afford them but more patients have coverage than youd think almost half of patients (47%) do
What This May Mean for Patients None of this regulatory context is unique to altRx, and altRx itself is one of many telehealth platforms operating in this space
While this is a single case report and not necessarily generalizable, it underscores why thyroid monitoring during GLP-1 therapy is not optional, it is essential
A 2024 meta-analysis focusing on PCOS patients revealed that GLP-1 receptor agonists significantly lowered fasting insulin levels, improved results on the 2-hour postoral glucose tolerance test, and reduced HOMA-IR, a key marker of insulin resistance
37 19381943.( 10.2337/dc13-2618) [DOI] [PubMed] [Google Scholar] 27.Ceriello A, Novials A, Ortega E, Canivell S, La Sala L, Pujadas G, Esposito K, Giugliano D, Genovese S
& Effectsize Estimation of effect size indices and standardized parameters
